Cover Image
市場調查報告書

美國的整形外科用生物學性、組織培養產品市場

U.S. Markets for Orthopedic Biologic and Tissue Engineered Products

出版商 Medtech Insight 商品編碼 329801
出版日期 內容資訊 英文 116 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
美國的整形外科用生物學性、組織培養產品市場 U.S. Markets for Orthopedic Biologic and Tissue Engineered Products
出版日期: 2015年05月01日 內容資訊: 英文 116 Pages
簡介

本報告提供美國的整形外科用生物學性、組織培養產品市場相關調查分析、新興與現有的細胞療法、主要的成長影響要素、市場佔有率與銷售額、正在開發新的細胞療法的生物技術企業、主要供應商的產品系列等系統性資訊。

第1章 肌肉骨骼系統疾病/障礙概要

  • 背痛和脊椎脊髓外科
  • 腕隧道症候群
  • 裘馨氏肌肉萎縮症
  • 骨關節炎
  • 骨質疏鬆症與骨折
  • 類風濕性關節炎

第2章 美國的生物學性肌肉骨骼系統軟組織再生、修復產品市場

  • 軟骨再生、修復技術
  • 韌帶、肌腱修復技術
  • 半月軟骨修復、再生技術

第3章 美國的生物學性肌肉骨骼系統硬組織再生、修復市場

  • 市售/正在開發的骨移植片、人工骨骼替代物
  • 生長因子基礎的骨移植片
  • 其他現在可以使用的/正在開發的生技藥品
  • 軟、硬組織修復、再生的細胞療法的新領域
  • 美國的肌肉骨骼系統硬組織再生、修復產品市場
  • 市場摘要:硬、軟組織培養、細胞療法產品

附錄:企業清單

目錄
Product Code: A428

Biologics and cellular therapies for musculoskeletal injuries-including hard tissue (i.e., bone) and soft tissue (i.e., cartilage, ligaments, and tendons)-represent a billion dollar market that is showing the potential for continued growth. Over the forecast period covered in this report, the estimated value of the U.S. market for orthopedic biologic and tissue engineered products is expected to grow by approximately $984.4 million at a compound annual growth rate (CAGR) of 8.2% to $3,014.1 million; of this holistic market, biologic and cellular therapies for hard musculoskeletal tissue are forecasted to grow at a CAGR of 7.2%, while soft musculoskeletal tissue products will grow at a CAGR of 10.6%.

This report will cover:

  • emerging and existing cellular therapies for hard and soft musculoskeletal tissue repair and regeneration;
  • key factors influencing the growth of individual product markets;
  • estimated market shares and sales among major U.S. suppliers
  • companies and biotech firms developing novel cellular therapies; and,
  • major supplier product portfolio analysis in individual product markets.

The scope of the analysis of this report covers companies developing and distributing biologics and novel cellular therapeutics for the treatment of musculoskeletal injuries. Hard tissue musculoskeletal products covered in this report include bone allograft and machined bone, demineralized bone matrix, growth factor-based bone grafts, cellular bone matrices, and select other biologics. Soft tissue musculoskeletal products covered by this report include cartilage regeneration and repair products, ligament and tendon repair technologies, and meniscus repair and regeneration products.

Methodology

Reports are produced exclusively by Medtech Insight, through extensive primary and secondary research among the clinicians, researchers, and competitors in the marketplace, and draw upon the industry expertise of a network of industry insiders. Medtech Insight exhaustively corroborates the data as a baseline for completing forward-looking analysis and providing insight into product, technology and market evolution.

Table of Contents

EXECUTIVE SUMMARY

  • i. Methodology
  • Exhibit ES-1: 2014, U.S. Orthopedic Biologic and Tissue Engineered Products Market, Share by Products

1. OVERVIEW OF MUSCULOSKELETAL DISEASES/DISORDERS

  • 1.1 Back Pain and Spine Surgery
  • 1.2 Carpal Tunnel Syndrome
  • 1.3 Duchenne Muscular Dystrophy
  • 1.4 Osteoarthritis
  • 1.5 Osteoporosis and Fractures
  • 1.6 Rheumatoid Arthritis
  • Exhibit 1-1: Musculoskeletal Surgery, Procedure Volumes Forecast, by Type, 2014-2019

2. U.S. MARKETS FOR BIOLOGIC MUSCULOSKELETAL SOFT TISSUE REGENERATION AND REPAIR PRODUCTS

  • 2.1 Cartilage Regeneration and Repair Technologies
    • 2.1.1 Currently Available Products
      • 2.1.1.1 Arthrex
      • 2.1.1.2 Vericel
      • 2.1.1.3 Zimmer
    • 2.1.2 Products in Development
      • 2.1.2.1 CellCoTec
      • 2.1.2.2 Cytori Therapeutics
      • 2.1.2.3 Histogenics
      • 2.1.2.4 ISTO Technologies
      • 2.1.2.5 Medipost
      • 2.1.2.6 TETEC
      • 2.1.2.7 TiGenix
      • 2.1.2.8 TissueGene
    • 2.1.3 Market Forecast
    • 2.1.4 Competitive Analysis
  • 2.2 Ligament and Tendon Repair Technologies
    • 2.2.1 Graft-Based Products Overview
    • 2.2.2 Tissue Engineering
      • 2.2.2.1 Biologic Scaffolds
      • 2.2.2.2 Developmental Biologic Scaffolds
    • 2.2.3 Market Forecast
    • 2.2.4 Competitive Analysis
  • 2.3 Meniscus Repair and Regeneration Technologies
    • 2.3.1 Products Overview
    • 2.3.2 Market Forecast
    • 2.3.3 Competitive Analysis
    • 2.2.4 U.S. Markets for Biologic Soft Tissue Regeneration and Repair Products
  • Exhibit 2-1: 2014, Cartilage Repair Procedures
  • Exhibit 2-2: Cartilage Repair and Regeneration Products, Market Forecast, 2014-2019
  • Exhibit 2-3: 2014, Knee Cartilage Repair and Regeneration Products Market, Share by Supplier
  • Exhibit 2-4: 2015, Selected Allografts for Ligament and Tendon Replacement
  • Exhibit 2-5: 2015, Biologic Scaffolds and Matrices for Ligament and Tendon Repair
  • Exhibit 2-6: Ligament and Tendon Replacement and Regeneration Products, Market Forecast, 2014-2019
  • Exhibit 2-7: 2014, Ligament and Tendon Replacement and Regeneration Products Market, Share by Supplier
  • Exhibit 2-8: 2015, Selected Biologic Meniscal Repair Products
  • Exhibit 2-9: Meniscal Replacement and Regeneration Products, Market Forecast, 2014-2019
  • Exhibit 2-10: 2014, Meniscal Replacement and Regeneration Products Market, Share by Supplier
  • Exhibit 2-11: Musculoskeletal Soft Tissue Biologics Products, Market Forecast, 2014-2019

3. U.S. MARKETS FOR BIOLOGIC MUSCULOSKELETAL HARD TISSUE REGENERATION AND REPAIR

  • 3.1 Bone Graft and Bone Substitute Products on the Market and Under Development
    • 3.1.1 Bone Autograft
    • 3.1.2 Bone Allografts and Machined Bone
    • 3.1.3 Demineralized Bone Matrix
    • 3.1.4 Market Forecast
    • 3.1.5 Competitive Analysis
  • 3.2 Growth Factor-Based Bone Grafts
    • 3.2.1 Products Overview
      • 3.2.1.1 Bioventus
      • 3.2.1.2 Medtronic
      • 3.2.1.3 Wright Medical Technology
    • 3.2.2 Market Forecast
    • 3.2.3 Competitive Analysis
  • 3.3 Other Biologics Currently Available or in Development
    • 3.3.1 Cellular Bone Matrices
      • 3.3.1.1 AlloSource
      • 3.3.1.2 Biomet
      • 3.3.1.3 NuVasive
      • 3.3.1.4 Orthofix
      • 3.3.1.5 Osiris Therapeutics
      • 3.3.1.6 RTI Surgical
    • 3.3.2 Cellular Regeneration Therapies in Development for Hard Bone Musculoskeletal Repair
      • 3.3.2.1 Cerapedics, Inc.
      • 3.3.2.2 Ferring Pharmaceuticals
      • 3.3.2.3 Mesoblast
    • 3.3.3 Market Forecast
    • 3.3.4 Competitive Analysis
  • 3.4 Emerging Areas of Cellular Therapy for Soft and Hard Tissue Repair and Regeneration
    • 3.4.1 Bone Marrow Aspirate Concentrate
    • 3.4.2 Gene Therapy
      • 3.4.2.1 Systemic Gene Therapy
      • 3.4.2.2 Regional Gene Therapy
    • 3.4.3 Three-Dimensional Printing
  • 3.5 U.S. Markets for Musculoskeletal Hard Tissue Regeneration and Repair Products
  • 3.6 Combined Market Summary for Hard and Soft Tissue Engineering and Cellular Therapy Products
  • Exhibit 3-1: 2015, Description and Representative Pricing of Base Allografts Used in Spine Surgery
  • Exhibit 3-2: 2015, Selected Bone Allograft and Machined Bone Products
  • Exhibit 3-3: 2015, Selected Demineralized Bone Matrix Products
  • Exhibit 3-4: Bone Allografts and Synthetic Bone Graft Substitutes, Market Forecast, 2014-2019
  • Exhibit 3-5: 2014, Bone Allograft Products Market, Share by Supplier
  • Exhibit 3-6: 2014, Demineralized Bone Matrix Products Market, Share by Supplier
  • Exhibit 3-7: Growth Factor-Based Products, Market Forecast, 2014-2019
  • Exhibit 3-8: 2014, Growth Factor-Based Products Market, Share by Supplier
  • Exhibit 3-9: Stem Cell Matrices and Other Osteobiologic Agents for Bone Healing and Enhancement of Spinal Fusion, Market Forecast, 2014-2019
  • Exhibit 3-10: 2014, Market Shares of Stem Cell Applications for Bone Healing and Spinal Fusion by Application
  • Exhibit 3-11: 2014, Stem Cell Products and Other Orthobiologics for Bone Healing and Spinal Fusion, Share by Supplier
  • Exhibit 3-12: U.S. Biologic Products for Musculoskeletal Hard Tissue Repair and Regeneration, Combined Market Forecast, 2014-2019
  • Exhibit 3-13: U.S. Hard and Soft Musculoskeletal Tissue Repair and Regeneration, Combined Procedure Volumes, 2014-2019
  • Exhibit 3-14: U.S. Biologic Products for Musculoskeletal Hard and Soft Tissue Repair and Regeneration, Combined Market Forecast, 2014-2019

APPENDIX: COMPANY LISTING

BIBLIOGRAPHY

Back to Top